Drug Naming
Creating safe drug names is at the heart of what we do.
OUR WORK
OUR SERVICES
CREATION
Global Brand Naming
Corporate Naming
Technology Naming
Delivery System Naming
Medical Device Naming
Drug Name Modifier Naming
Medical Condition Naming
Animal Health Naming
STRATEGY
Brand Name Consulting
Brand Strategy
Corporate Identity Development
Name Launch Communications
Segment Identifier Development
Ideation / Workshops
RESEARCH
Consumer/Patient Market Research
Global Linguistic Screening
Global Trademark Screening
HCP/Pharmacist Market Research
Medication Safety Analysis
Name Attribute Evaluation
Name Prescreening
Regulatory Consult
Regulatory Rebuttal
Regulatory Submission & Reports
Trademark Filing
IF YOU NEED A NEW BRAND NAME FOR A NEW DRUG AND WANT TO WORK WITH ONE OF THE INNOVATORS IN PHARMACEUTICAL BRAND NAMING FIELD GARY IS THE FIRST PERSON YOU SHOULD CALL.
GARY IS NOT ONLY CREATIVE AND INNOVATIVE HE KNOWS THE BRAND NAMING RESEARCH AND REGULATIONS GAME INSIDE AND OUT. GARY IS A STRATEGIC PARTNER AND A GREAT TEAM PLAYER THAT HAS A PROVEN PROCESS TO HELP YOU DEVELOP THE BRAND NAME THAT WILL NOT ONLY BE MEMORABLE, RESONATE, AND MOTIVATE YOUR CUSTOMERS IT WILL BE EASY TO WRITE, DISPENSE AND MOST IMPORTANTLY KEEP YOUR CUSTOMERS SAFE.
–KEN HERMAN, WHILE AT ARENA PHARMACEUTICALS
OUR EXPERIENCE
YEARS OF DRUG
NAMING EXPERIENCE
APPROVED
DRUG NAMES
SUCCESSFUL COMPANY
RELATIONSHIPS
20+
200+
2000+
Abbott
Abelcet
Actelion
Advil
Alexion
Allergan
Alza
Amgen
AstraZeneca
Bausch & Lomb
Baxter
Biogen
BioMarin
Biomira
Bisolvon
Bristol-Myers Squibb
Caelyx
Cayston
Celebrex
Chiron
Colgate
Connetics
Corus
Dendreon
Edwards Life Sciences
Elan
Eli Lilly
EMD
Enablex
Enbrel
Erbitux
Extina
Exubera
Forest
Ganfort
Genentech
Gilead
Hospira
ImClone
Inex
Intarcia
Iressa
Janssen
Johnson & Johnson
Kaletra
Kiovig
Kosan
La Jolla
LifeScan
Luxiq
Marqibo
Maxim
Medtronic
Merck (DuPont Merck)
Merck KGaA
Miraluma
Motrin IB
Mucosolvan
Nektar
NeoRx
Novartis
NPS
Nuvelo
Olux
Ortho-McNeil
PDL
Pfizer
Preos
Prolia
Procter & Gamble
Questcor
Relpax
Repatha
Replidyne
Roche
Sensipar
Soliris
Sonata
Sureclick
Theravance
Tracleer
TransOral
Veletri
Verluma
Vfend
Viadur
Viagra
Vertex
Vivus
Wyeth
Xtent
Xolair
Zevalin
Zomig
Zymar
Zyrtec
NOTE: Gary Martin led these and many other naming engagements as managing director at leading branding firms.
OUR CLIENTS
 |  |  |  |  |
|---|---|---|---|---|
 |  |  |  |  |
 |  |  |  |  |
CASE STUDIES
DRUG NAMING: HELPING YOU AT ALL STAGES OF DEVELOPMENT
PHASE III
FIXING A
REGULATORY JAM
PHASE II
CREATING A
GLOBAL BRAND
POST-LAUNCH
RETAINING
BRAND EQUITY
PHASE I
NAMING
CLINICAL TRIALS
CASE STUDY SNAPSHOT: SUCCESS IN PROGRESS
HOW YOU CAN EARN
THE THUMBS UP
IN YOUR COMPANY,
AND BECOME A DRUG-NAMING ROCK STAR TOO!
Diane, a key member of a biopharma start-up, needed help naming their late-stage compound, or else face costly delays at FDA.
Her problem was that no one at the small company had ever engaged in drug naming before, and she wasn't sure what to budget. When she called us, we offered free advice and outlined several naming options at her disposal.
She opted to bring us on board, and our team went right to work. Using proprietary tools to gather Diane’s team input, we quickly created a large pool of potential drug names. Several of our names proved to resonate with her senior managers, and that helped Diane convince them to stay on course with naming and avoid trouble.
We were delighted... first because Diane was a fantastic partner who turned to us as her advisor. But what really warmed our hearts was that she's now famously known inside her company as the "naming guru."
We are betting that this sobriquet will soon change to “Naming Guru–VP."
(Diane is a fictitious name but her story is real. At this time, there is no public brand name announcement. As is sometimes the case with start-ups, flying underneath the radar is preferred. We respect our client's privacy.)
